HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute and short-term effects of nitrendipine and diltiazem at rest and during exercise in hypertensive patients.

Abstract
The subjects were 30 patients with mild-to-moderate hypertension randomly assigned to receive 10 mg of nitrendipine twice daily or 60 mg of diltiazem thrice daily for 14 days. On days 1 and 14 the patients performed an effort test (to a maximum of 100 W) before and after drug administration. Both nitrendipine and diltiazem reduced systolic and diastolic blood pressure; after 14 days of treatment, the reductions in blood pressure were significantly greater in the nitrendipine-treated patients than in the diltiazem-treated patients. Blood pressures were reduced at maximum effort in both treatment groups before drug administration on day 14 compared with day 1. Two hours after drug administration on days 1 and 14, the reductions in effort blood pressures were significantly greater after nitrendipine than after diltiazem. No side effects were noted in either group. It is concluded that nitrendipine is safe and effective in patients with mild-to-moderate hypertension at rest and during exercise.
AuthorsG Gambini, C Valori, L Bianchi, M Bozza
JournalClinical therapeutics (Clin Ther) 1991 Nov-Dec Vol. 13 Issue 6 Pg. 680-6 ISSN: 0149-2918 [Print] United States
PMID1790542 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Nitrendipine
  • Diltiazem
Topics
  • Blood Pressure (drug effects)
  • Diltiazem (therapeutic use)
  • Exercise Test
  • Female
  • Humans
  • Hypertension (drug therapy)
  • Male
  • Middle Aged
  • Nitrendipine (therapeutic use)
  • Rest
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: